Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Moodys
Accenture
Argus Health
Fish and Richardson
Queensland Health
Chubb
Johnson and Johnson
Chinese Patent Office

Generated: August 18, 2018

DrugPatentWatch Database Preview

Natco Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for NATCO PHARMA, and what generic and branded alternatives to NATCO PHARMA drugs are available?

NATCO PHARMA has nineteen approved drugs.

There is one tentative approval on NATCO PHARMA drugs.

Summary for Natco Pharma
US Patents:0
Tradenames:16
Ingredients:16
NDAs:19
Patent Litigation for Natco Pharma: See patent lawsuits for Natco Pharma

Drugs and US Patents for Natco Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Natco Pharma Ltd GLYCOPYRROLATE glycopyrrolate TABLET;ORAL 091413-001 Jun 20, 2016 AA RX No No ➤ Sign Up ➤ Sign Up
Natco Pharma Ltd LANSOPRAZOLE lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 201921-001 Dec 18, 2012 AB RX No No ➤ Sign Up ➤ Sign Up
Natco Pharma Ltd LANTHANUM CARBONATE lanthanum carbonate TABLET, CHEWABLE;ORAL 090978-002 Aug 11, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Natco Pharma Ltd CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 090612-001 Jan 21, 2011 AA RX No Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Baxter
Dow
Healthtrust
QuintilesIMS
Chubb
Accenture
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.